CASE REPORT Pazopanib for metastatic p e

can be determined for recommended treatment options. h th dia of the malignant cells, with some or all of the vascular-endothelial markers (CD31, CD34 and factor VIII) [3]. chest pain in the preceding 3 months. She had no prior medical history, was a non-smoker, and denied any Semenisty et al. BMC Cancer (2015) 15:402 DOI 10.1186/s12885-015-1395-6endothelial growth factor receptor 1 (VEGFR1), and was found to be strongly positive (Fig. 1b)